Effects of eicosepenteanoic acid on ventricular arrhythmia:a prospective,open-labeled,randomized controlled clinical trial
Not Applicable
- Conditions
- ventricular tachycardia ventricular fibrillation
- Registration Number
- JPRN-UMIN000022506
- Lead Sponsor
- Hirosaki University Graduate School of Medicine Department of Cardiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1)Allergy against eicosapentaenoic acid 2)Patients with malignant neoplasm 3)Subjects whose doctor in charge do not agree to join the trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint was appropriate ICD therapy for VT/VF confirmed by stored electrograms, or death from any cause.
- Secondary Outcome Measures
Name Time Method